Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemia

Bone Marrow Transplantation

Volumn 29, Issue 4, 2002, Pages 291-295

  Singhal, S ^a,b   Powles, R ^a   Henslee Downey, P J ^b   Chiang, K Y ^b   Treleaven, J ^a   Godder, K ^b   Kulkarni, S ^a   van Rhee, F ^b   Sirohi, B ^a   Pinkerton, C R ^a   Meller, S ^a   Mehta, J ^a,b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b South Carolina Cancer Center   (United States)

Author keywords

Graft versus leukemia; Hematopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOGRAFT; ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LIVING DONOR; MALE; PRIORITY JOURNAL; RECIPIENT; SIBLING; SURVIVAL RATE; TIME; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; LEUKEMIA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LIVING DONORS; MALE; MIDDLE AGED; NUCLEAR FAMILY; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 85047699216     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703373     Document Type: Article

References (20)

1. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report
2. Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
3. Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia
4. The impact of karyotype on remission rates in adult patients with de novo acute myeloid leukemia receiving high-dose cytarabine-based induction chemotherapy
5. Treatment of patients with acute nonlymphocytic leukemia not in remission
6. Total therapy of acute myeloid leukemia: 7-year follow-up
7. Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy
8. Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia
9. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy
10. Bone marrow transplantation for primary refractory acute leukemia
11. Allogeneic bone marrow transplantation from partially mismatched related donors as therapy for primary induction failure acute myeloid leukemia
12. Graft-versus-leukemia reactions in clinical bone marrow transplantation
13. Use of partially mismatched related donors extends access to allogeneic marrow transplant
14. Haploidentical BMT for acute leukemia: Single-center experience of 220 patients
15. Use of a closed system for Vαβ-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation
16. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial
17. + cells/kg be considered the minimum threshold?
18. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant
19. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
20. Allogeneic related partially mismatched transplantation